ATE106252T1 - Verfahren und materialien zur herstellung der lösungen von metallmarkierten antikörpern. - Google Patents

Verfahren und materialien zur herstellung der lösungen von metallmarkierten antikörpern.

Info

Publication number
ATE106252T1
ATE106252T1 AT88118414T AT88118414T ATE106252T1 AT E106252 T1 ATE106252 T1 AT E106252T1 AT 88118414 T AT88118414 T AT 88118414T AT 88118414 T AT88118414 T AT 88118414T AT E106252 T1 ATE106252 T1 AT E106252T1
Authority
AT
Austria
Prior art keywords
metal
preparing
solutions
materials
methods
Prior art date
Application number
AT88118414T
Other languages
English (en)
Inventor
David K Johnson
Patrick E Rogers
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26816013&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE106252(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/118,148 external-priority patent/US5130118A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE106252T1 publication Critical patent/ATE106252T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88118414T 1987-11-06 1988-11-04 Verfahren und materialien zur herstellung der lösungen von metallmarkierten antikörpern. ATE106252T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/118,148 US5130118A (en) 1987-11-06 1987-11-06 Methods and materials for the preparation of metal labelled antibody solutions
US26173788A 1988-10-26 1988-10-26

Publications (1)

Publication Number Publication Date
ATE106252T1 true ATE106252T1 (de) 1994-06-15

Family

ID=26816013

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88118414T ATE106252T1 (de) 1987-11-06 1988-11-04 Verfahren und materialien zur herstellung der lösungen von metallmarkierten antikörpern.

Country Status (7)

Country Link
EP (1) EP0315188B1 (de)
JP (2) JP2792871B2 (de)
KR (1) KR890007756A (de)
AT (1) ATE106252T1 (de)
AU (1) AU619218B2 (de)
DE (1) DE3889851T2 (de)
ES (1) ES2056875T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
EP0403243B1 (de) * 1989-06-16 1995-11-08 Merck Frosst Canada Inc. Chelat-Derivate von atrialnatriurethischem Faktor (ANF)
CA2066779A1 (en) * 1989-09-22 1991-03-23 Jean-Luc Vanderheyden Stable therapeutic radionuclide compositions and methods for preparation thereof
EP0709100A1 (de) * 1994-09-30 1996-05-01 Nihon Medi-Physics Co., Ltd. Kontrastmittel mit mehreren Detektionsgruppen pro Molekül
US6107090A (en) 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
US20020102208A1 (en) 1999-03-01 2002-08-01 Paul Chinn Radiolabeling kit and binding assay
MY133346A (en) 1999-03-01 2007-11-30 Biogen Inc Kit for radiolabeling ligands with yttrium-90
US7514078B2 (en) 2001-06-01 2009-04-07 Cornell Research Foundation, Inc. Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
WO2002098897A2 (en) 2001-06-01 2002-12-12 Cornell Research Foundation, Inc. Modified antibodies to prostate-specific membrane antigen and uses thereof
EP1277728A1 (de) * 2001-07-18 2003-01-22 University of Lausanne Neue TTDA Derivate und deren Verwendung als Gadolinium Komplexbildner für MRI Bilderzeugung
EP1427377A4 (de) 2001-09-20 2006-04-12 Cornell Res Foundation Inc Verfahren und zusammensetzungen zur behandlung oder prävention von hauterkrankungen unter verwendung von bindemitteln, die für das prostataspezifische membranantigen spezifisch sind
ATE408712T1 (de) 2003-01-10 2008-10-15 Millennium Pharm Inc Verfahren zur bestimmung des wiederauftretens von prostata krebs
JP7816003B2 (ja) * 2022-06-06 2026-02-18 Ｊｆｅエンジニアリング株式会社 放射性物質の標識方法
EP4583999A1 (de) * 2022-09-09 2025-07-16 Bristol-Myers Squibb Company Verfahren zur trennung eines chelatbildners

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2122641B (en) * 1982-06-07 1986-08-06 Otto A Gansow Metal chelate conjugated monoclonal antibodies where in the metal is an emitter
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
US4636380A (en) * 1984-04-23 1987-01-13 Wong Dennis W Novel physiologic chemical method of labeling protein substances with the radionuclides of indium
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments

Also Published As

Publication number Publication date
JP3074160B2 (ja) 2000-08-07
DE3889851T2 (de) 1994-09-08
ES2056875T3 (es) 1994-10-16
JPH10330289A (ja) 1998-12-15
DE3889851D1 (de) 1994-07-07
KR890007756A (ko) 1989-07-05
AU2466488A (en) 1989-07-27
EP0315188A2 (de) 1989-05-10
JPH01250327A (ja) 1989-10-05
JP2792871B2 (ja) 1998-09-03
EP0315188B1 (de) 1994-06-01
AU619218B2 (en) 1992-01-23
EP0315188A3 (en) 1990-01-10

Similar Documents

Publication Publication Date Title
ATE106252T1 (de) Verfahren und materialien zur herstellung der lösungen von metallmarkierten antikörpern.
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
ATE329624T1 (de) Technetium-99m markierte peptide zur bilderzeugung von thrombus
DE68924795D1 (de) Verfahren zur Radiomarkierung von Proteinen.
EP0038546A3 (en) Radiolabeled diagnostic compositions and method for making the same
DE3687402D1 (de) Thrombinzusammensetzung.
ATE17404T1 (de) Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung.
ATA222686A (de) Verfahren zur herstellung von se-metallen und se-haltigen legierungen
TW262536B (de)
JPS5576954A (en) Direct quantitative determination method of serum iron and composition for excuting the same
DE59404688D1 (de) Verfahren zur Direktreduktion von eisenoxidhaltigen Materialien mit festen kohlenstoffhaltigen Reduktionsmitteln
IT1241154B (it) Metodo e composizione reagente per la determinazione dell'alanina amminotrasferasi e dell'antigene hbsag in uno stesso campione biologico
DK509485D0 (da) Toerstof til fremstilling af stabile suspensioner indeholdende 4-hydroxy- eller 4-acyloxy-4-androsten-3,17-dioner samt dets fremstilling og anvendelse
ATE26108T1 (de) Neue tetra(meth)acrylsaeureverbindungen und deren verwendung.
NO177461C (no) Trijodbenzenforbindelser og kontrastmidler inneholdende disse
DE69006042D1 (de) Zusammensetzung von nichtlinearen Materialien und Verfahren zur Herstellung.
ATE77487T1 (de) Immunologisches bestimmungsverfahren zur bestimmung von hapteneigenschaften aufweisenden freien substanzen.
ATE15109T1 (de) Verfahren zur herstellung einer chromogenen reaktionsmischung zur bestimmung der eisenkonzentration und -bindungskapazitaet von serum sowie die dabei erhaltene chromogene reaktionsmischung.
DE69401994D1 (de) Verfahren zur Herstellung von Siliciumnitridpulver hohem Alpha-Gehalt
GR3020389T3 (en) Calibrator and use thereof in an immuno-assay
ZA832293B (en) Chromophoric peptides,a process for their preparation,agents containing them and their use for determining dd-carboxypeptidases
DE69016249D1 (de) Verfahren zur elektrochemischen Behandlung von Schwefelwasserstoff enthaltendem Gas.
DE3482308D1 (de) Verfahren zur radioaktiven markierung von blutzellen und zusammensetzungen dafuer.
ES2053704T3 (es) Un metodo de estabilizacion de una composicion acuosa consistente en uno o mas anticuerpos monoclonales.
EP0163122A3 (en) Method for the determination of free substances in biological fluids

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked